Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity with therapeutic design directed at human leukocyte antigens.

BioBoss

#37 - Nandan Padukone: CEO of IM Therapeutics

BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen each month as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you make change? Why should I care?" to a new biopharma executive and hear insights on this rapidly changing field.

About

BioBoss